Halper Sadeh Launches Investigations into Four Corporate Mergers

The investigation targets the sale of RXO Inc. to C.H. Robinson Worldwide, where shareholders are slated to receive $17.25 in cash plus 0.0856 shares of common stock. Similarly, the firm is reviewing PTC Inc.’s $205.00 per share cash deal with Schneider Electric and the acquisition of Lifecore Biomedical by Webster Equity Partners, which includes a contingent value right. The firm is also looking into the merger between WaFd, Inc. and EverBank Financial Corp., where WaFd investors are expected to retain a 40.8% stake in the combined entity.

Halper Sadeh alleges that these transactions may contain restrictive terms that discourage superior competing offers or provide insiders with benefits unavailable to the broader investor base. The firm, based in New York, aims to secure increased consideration or improved disclosures for shareholders. These legal inquiries operate on a contingent fee basis, meaning investors do not incur out-of-pocket expenses for the firm's representation. Attorneys Daniel Sadeh and Zachary Halper are leading the efforts to determine if these mergers violate federal securities laws.